GLP-1 receptor agonists, including semaglutide, reduce alcohol intake and relapse-like behaviors in rodent and non-human primate models, and a recent clinical trial found that semaglutide decreased alcohol craving and drinking in adults with AUD
Clinical trials showed that GLP-1 agonists improved blood sugar control while also causing weight loss as an unexpected side effect, which intrigued researchers exploring metabolic therapies
This preclinical evidence supports the role of the GLP-1 system in alcohol use disorders and suggests that GLP-1 receptor agonists could be effective in treating AUD
If you cannot refrigerate your pen for one injection day, it remains stable at room temperature below 86F for up to 30 days total
Rivestimento capsule: idrossipropilmetilcellulosa
A regulated form of necrosis, known as necroptosis, is a caspase-independent cell death mechanism that displays typical features of necrosis, including morphological alterations, subcellular changes, and metabolic dysfunction